A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation Recipients

NCT01513850 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

DRUG: Hepabulin IV

Sponsor

SK Chemicals Co., Ltd.